Display options
Share it on

Korean J Anesthesiol. 2013 Jan;64(1):47-53. doi: 10.4097/kjae.2013.64.1.47. Epub 2013 Jan 21.

The effects of an insulin-glucose-potassium (IGK) pretreatment on the bupivacaine cardiotoxicity.

Korean journal of anesthesiology

Jin-Tae Kim, Sol-Mon Yang, Kook Hyun Lee

Affiliations

  1. Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.

PMID: 23372886 PMCID: PMC3558649 DOI: 10.4097/kjae.2013.64.1.47

Abstract

BACKGROUND: The purpose of this study is to evaluate the effect of an IGK pretreatment on the cardiotoxicity of bupivacaine.

METHODS: Twenty-one anesthetized mongrel dogs were randomly divided into the following three groups: the control group (CG, n = 7), the treatment group (TG, n = 7) and the pretreatment group (PTG, n = 7). For the 30 min of pretreatment period, CG and TG received normal saline, while PTG received an IV bolus of insulin 2 U/kg, followed by an IGK infusion (2 U/kg/hr of insulin, 0.5-1.5 g/kg/hr of glucose, 1-2 mEq/kg/hr of KCl). The bupivacaine infusion was started at the rate of 0.5 mg/kg/min in all groups after the pretreatment period. CG received normal saline only. In TG, insulin (2 U/kg) was injected simultaneously with bupivacaine infusion, followed by the IGK infusion as with PTG. The hemodynamic variables and the time duration to reach the mean arterial pressure (MAP) of 60 mmHg were compared.

RESULTS: The bupivacaine infusion decreased the cardiac index, MAP, and heart rate in all three groups. Although insulin concentration was higher in TG than in PTG during bupivacaine infusion, the hemodynamic variables in PTG decreased at the slowest rate. The time taken to reach MAP of 60 mmHg in PTG, TG, and CG was 51.4 ± 8.5, 36.4 ± 9.6, and 27.1 ± 8.7 min, respectively (P < 0.05).

CONCLUSIONS: IGK delays the bupivacaine-induced cardiac depression. However, a pretreatment with IGK is more effective in delaying the bupivacaine-induced hypotension than simultaneous administration, regardless of insulin concentration.

Keywords: Bupivacaine; Cardiotoxicity; Dog; Insulin

References

  1. J Cardiovasc Pharmacol. 1987 Sep;10(3):259-67 - PubMed
  2. Anesth Analg. 2000 Nov;91(5):1096-102 - PubMed
  3. J Pharmacol Exp Ther. 1990 Dec;255(3):1038-46 - PubMed
  4. Anesth Analg. 1986 Jun;65(6):551-9 - PubMed
  5. Pflugers Arch. 1992 Dec;422(3):267-72 - PubMed
  6. Ann Thorac Surg. 2003 Feb;75(2):S721-8 - PubMed
  7. Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):131-9 - PubMed
  8. Anesth Analg. 1992 May;74(5):698-702 - PubMed
  9. Anesth Analg. 1994 Feb;78(2):335-9 - PubMed
  10. Anesthesiology. 1985 Apr;62(4):396-405 - PubMed
  11. Am J Physiol. 1998 Apr;274(4):E642-50 - PubMed
  12. Circulation. 1997 Dec 2;96(11):4104-13 - PubMed
  13. Am J Cardiol. 1977 Sep;40(3):421-8 - PubMed
  14. J Biol Chem. 1990 May 15;265(14):7837-42 - PubMed
  15. Circulation. 2006 Jul 4;114(1 Suppl):I239-44 - PubMed
  16. Circulation. 1997 Aug 19;96(4):1152-6 - PubMed
  17. Am J Cardiol. 1976 Sep;38(3):310-21 - PubMed
  18. Biochem J. 1990 Oct 1;271(1):269-72 - PubMed
  19. Anesth Analg. 1989 Dec;69(6):732-5 - PubMed
  20. Anesthesiology. 2002 Nov;97(5):1168-77 - PubMed
  21. Metabolism. 1992 Jul;41(7):711-6 - PubMed
  22. Eur J Anaesthesiol. 2007 Apr;24(4):340-6 - PubMed
  23. Am J Cardiol. 1979 Apr;43(4):801-9 - PubMed
  24. Anesth Analg. 2004 Sep;99(3):728-733 - PubMed
  25. Anesthesiology. 2004 Oct;101(4):888-94 - PubMed
  26. Anesth Analg. 2001 Apr;92(4):1075-6 - PubMed
  27. Cardiovasc Surg. 1999 Oct;7(6):645-50 - PubMed
  28. J Mol Cell Cardiol. 1998 Oct;30(10):2025-35 - PubMed
  29. Circ Res. 1970 Nov;27(5):835-49 - PubMed
  30. Anesthesiology. 1979 Oct;51(4):285-7 - PubMed

Publication Types